Comprehensive analysis of SYTL4 differential expression and clinical implications in DLBCL
Background Diffuse large B-cell lymphoma (DLBCL), a common type of non-Hodgkin lymphoma (NHL), is associated with heterogeneous clinical outcomes, with a subset of patients experiencing refractory disease or relapse, underscoring the need for novel biomarkers to refine risk stratification. This study aimed to investiga...